Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/20/2021 73 14
Remdesivir Approved by FDA Experimental Antiviral Jan/19/2021 49 4
Emetine Potential treatment - pre-clinical evidence Experimental Antiviral Jan/15/2021 6 0
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Jan/14/2021 4 0
Fostamatinib Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Dec/24/2020 2 0
Nitazoxanide Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/24/2020 5 1
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/14/2020 11 3
BNT162b2 Emergency use authorization Experimental Vaccine Dec/11/2020 5 0
sMVA-N Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020 1 0